PDT Partners LLC Acquires New Stake in Privia Health Group, Inc. $PRVA

Key Points

• PDT Partners LLC has acquired a new stake in Privia Health Group, purchasing 86,499 shares valued at approximately $1.94 million.
• Research analysts have set a consensus price target of $28.08 for Privia Health Group, with most ratings reflecting a general outlook of "Moderate Buy".
• Despite a revenue increase of 23.4% year-over-year, Privia Health reported earnings that missed projections, with an EPS of $0.02, below the expected $0.05.

PDT Partners LLC acquired a new stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 86,499 shares of the company's stock, valued at approximately $1,942,000. PDT Partners LLC owned approximately 0.07% of Privia Health Group as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. US Bancorp DE raised its position in Privia Health Group by 2.4% in the 1st quarter. US Bancorp DE now owns 18,487 shares of the company's stock worth $415,000 after buying an additional 429 shares during the last quarter. Park Avenue Securities LLC raised its position in Privia Health Group by 3.6% in the 1st quarter. Park Avenue Securities LLC now owns 15,229 shares of the company's stock worth $342,000 after buying an additional 532 shares during the last quarter. CWM LLC raised its position in Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company's stock worth $40,000 after buying an additional 604 shares during the last quarter. Financial Management Professionals Inc. lifted its holdings in Privia Health Group by 28.7% in the first quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock valued at $76,000 after acquiring an additional 754 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after acquiring an additional 1,521 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Price Performance

Shares of Privia Health Group stock traded up $0.16 on Friday, reaching $23.28. The company had a trading volume of 1,195,157 shares, compared to its average volume of 769,728. The firm has a market cap of $2.86 billion, a price-to-earnings ratio of 211.66, a P/E/G ratio of 3.37 and a beta of 0.82. The firm's 50-day moving average price is $21.04 and its two-hundred day moving average price is $22.58. Privia Health Group, Inc. has a 1 year low of $16.47 and a 1 year high of $26.09.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). The company had revenue of $521.15 million during the quarter, compared to analysts' expectations of $466.97 million. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.Privia Health Group's revenue for the quarter was up 23.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.19 EPS. Privia Health Group has set its FY 2025 guidance at EPS. As a group, analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Stephens reissued an "overweight" rating and issued a $32.00 price objective on shares of Privia Health Group in a report on Thursday. Evercore ISI decreased their price objective on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 9th. JPMorgan Chase & Co. lifted their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a research report on Wednesday, May 28th. JMP Securities lifted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "market outperform" rating in a research report on Friday, August 29th. Finally, Piper Sandler reduced their price objective on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating on the stock in a research report on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $28.58.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.